Safety and Efficacy of Oral Flecainide Acetate in Patients with Cardiac Arrhythmias

We retrospectively studied the clinical efficacy and safety of oral flecainide in 38 patients with symptomatic arrhythmias. Patients received 100 to 200mg daily of flecainide for a mean of 25 months (range 8 to 50 months). All patients had normal cardiac function. Paroxysmal atrial fibrillation (PAF...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Japanese Heart Journal 1997, Vol.38(3), pp.379-385
Hauptverfasser:	NAKAZATO, Yuji, NAKATA, Yasuro, YASUDA, Masayuki, NAKAZATO, Kaoru, SUMIYOSHI, Masataka, OGURA, Shunsuke, YAMAGUCHI, Hiroshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adolescent Adult Aged Anti-Arrhythmia Agents - administration & dosage Anti-Arrhythmia Agents - adverse effects Antiarythmic agents Arrhythmias, Cardiac - drug therapy Arrhythmias, Cardiac - physiopathology Biological and medical sciences Cardiovascular system Child Drug Evaluation Electrocardiography - drug effects Female Flecainide Flecainide - administration & dosage Flecainide - adverse effects Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Proarrhythmia Retrospective Studies ST elevation Stroke Volume - drug effects Tachycardia, Supraventricular - drug therapy Tachycardia, Supraventricular - physiopathology Ventricular Function
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!